Figure 4From: In vivo therapeutic efficacy and pharmacokinetics of colistin sulfate in an experimental model of enterotoxigenic Escherichia coli infection in weaned pigs Evolution of body weight in pigs receiving colistin sulfate (CS) orally at a dose of 50 000 IU/kg (mean ± standard deviation [SD]). Challenge was performed at d-2 and treatment with colistin sulfate (CS) at the dose of 50 000 IU/kg. For each sampling time, means with different letters on a given day are statistically different. At d-3 and d-6 there was no significant difference between groups.Back to article page